Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status is updated to indicate the study is closed to new participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. The Intervention/Treatment heading formatting was standardized (adding 'Intervention/Treatment' and removing the variant 'Intervention / Treatment'), and the revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check9 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a small backend update to the page's version history.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows a Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor system update rather than any change to the study content or user-facing information.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, representing a small platform update to the page. This change does not modify study content, eligibility, or results.SummaryDifference0.0%

- Check59 days agoChange DetectedPage revision updated to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and a link to the Genetic and Rare Diseases Information Center in the page's Resources section.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.